Trial intelligence / Profile preview

Tovorafenib versus standard chemotherapy in first-line pediatric low-grade glioma with RAF alteration

NL-OMON53920Phase 3Recruiting

Sponsor

Day One Biopharmaceuticals

Start

Feb 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1